Research is being conducted on harnessing glycolysis in gastric cancer, exploring molecular targets and therapeutic strategies. The focus areas include the role of metabolic and epigenetic drivers in cancer, as well as the potential of immunotherapy and targeted interventions. Various studies are investigating different approaches to overcoming resistance and improving treatment efficacy in cancer, including the use of artificial intelligence and immune system modulation.